Recombinant human interleukin-1 receptor antagonist in severe traumatic brain injury: a phase II randomized control trial

Traumatic brain injury (TBI) is the commonest cause of death and disability in those aged under 40 years. Interleukin-1 receptor antagonist (IL1ra) is an endogenous competitive antagonist at the interleukin-1 type-1 receptor (IL-1R). Antagonism at the IL-1R confers neuroprotection in several rodent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Helmy, Adel, Guilfoyle, Mathew R, Carpenter, Keri LH, Pickard, John D, Menon, David K, Hutchinson, Peter J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4013762/
https://ncbi.nlm.nih.gov/pubmed/24569690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jcbfm.2014.23
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados